Brief: Rainmed Medical Says Unit To Acquire 57% Intrest In Tianjin Yuehekang Biotechnology
01/03/2023 13:29
March 1 (Reuters) - Rainmed Medical Ltd 2297.HK :
* UNIT TO ACQUIRE 57% INTREST IN TIANJIN YUEHEKANG
BIOTECHNOLOGY
* SUZHOU RAINMED TO SUBSCRIBE FOR INCREASED REGISTERED
CAPITAL ON
A FULLY-DILUTED BASIS FOR RMB10 MILLION
* SUZHOU RAINMED TO SUBSCRIBE FOR INCREASED REGISTERED
CAPITAL OF
TIANJIN YUEHEKANG BIOTECHNOLOGY
* ACQUISITION OF TIANJIN YUEHEKANG FOR RMB16 MILLION
Source text for Eikon: ID:nHKS6YLHv0
Further company coverage: 2297.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rainmed Medical
See all newsChina's Rainmed Medical H1 revenue rises, net loss narrows
Brief: Rainmed Medical Says Zhu Zeke Resigns As Executive Director And Joint CEO
Brief: Rainmed Medical Posts FY Loss Attributable RMB77.1 Million
Brief: Rainmed Medical Says Huo Yunfei Resigned As A CEO
Brief: Rainmed Medical To Issue 233.6 Million Shares